Capital International’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8M | Buy |
221,889
+251
| +0.1% | +$27K | 0.91% | 30 |
|
|
2025
Q1 | $22.4M | Buy |
221,638
+16,902
| +8% | +$1.71M | 0.97% | 30 |
|
|
2024
Q4 | $18.3M | Buy |
204,736
+98,646
| +93% | +$8.81M | 0.75% | 37 |
|
|
2024
Q3 | $8.89M | Buy |
106,090
+35,430
| +50% | +$2.97M | 0.38% | 76 |
|
|
2024
Q2 | $5.44M | Buy |
70,660
+6,954
| +11% | +$536K | 0.25% | 92 |
|
|
2024
Q1 | $4.36M | Buy |
+63,706
| New | +$4.36M | 0.21% | 105 |
|
|
2021
Q1 | – | Sell |
-57,861
| Closed | -$2.08M | – | 157 |
|
|
2020
Q4 | $2.08M | Sell |
57,861
-342,830
| -86% | -$12.3M | 0.12% | 125 |
|
|
2020
Q3 | $15.3M | Buy |
400,691
+4,674
| +1% | +$179K | 1.04% | 26 |
|
|
2020
Q2 | $13.9M | Sell |
396,017
-5,329
| -1% | -$187K | 1.3% | 22 |
|
|
2020
Q1 | $13.1M | Sell |
401,346
-14,848
| -4% | -$484K | 1.47% | 17 |
|
|
2019
Q4 | $18.8M | Buy |
416,194
+131,058
| +46% | +$5.93M | 1.98% | 10 |
|
|
2019
Q3 | $11.6M | Buy |
285,136
+143,506
| +101% | +$5.84M | 1.75% | 13 |
|
|
2019
Q2 | $6.09M | Buy |
141,630
+716
| +0.5% | +$30.8K | 1.45% | 16 |
|
|
2019
Q1 | $5.41M | Hold |
140,914
| – | – | 1.3% | 19 |
|
|
2018
Q4 | $4.98M | Buy |
140,914
+6,026
| +4% | +$213K | 1.35% | 18 |
|
|
2018
Q3 | $5.19M | Buy |
134,888
+6,976
| +5% | +$269K | 1.62% | 12 |
|
|
2018
Q2 | $4.18M | Hold |
127,912
| – | – | 0.73% | 47 |
|
|
2018
Q1 | $3.5M | Buy |
127,912
+10,832
| +9% | +$296K | 0.63% | 55 |
|
|
2017
Q4 | $2.9M | Buy |
+117,080
| New | +$2.9M | 0.55% | 63 |
|